{
    "offres": "{\"US\": {\"sponsor_id\": \"2\", \"image\": \"19500_3.webp\", \"domain\": \"www.forwardservertech.com\", \"unsub_domain\": \"www.centspacesalt.com\", \"offre_id\": \"3M8MNP5/27J4HSD9\", \"unsub_id\": \"o-bzjh-w28-37d94c518622ede963b81d378bd96887\", \"c2\": \"bozel\"}}",
    "subjects": "{\"US\": [\"Linda M: I honestly cried when I saw the meter\", \"Sugar dropped to 97 in 7 days\", \"My dad got off insulin in 2 weeks\", \"She cried when she saw 97 mg/dL\", \"12 years of insulin gone in 14 days\", \"I ate carbs and my sugar stayed down\", \"Deborah W: This is real\", \"Re: Your blood sugar reading\", \"97 mg/dL... is this even possible?\", \"Did you see Linda\u2019s results?\", \"Authority & News Angle\", \"11. 60 Minutes: The segment Big Pharma hates\", \"12. Dr. Phil: Do this before bed (It works)\", \"13. CBS Alert: New Type 2 Discovery\", \"14. Dr. Phil exposes the 30-second ritual\", \"15. Breaking: The insulin industry is panicking\", \"16. Sunday Special: The End of Diabetes?\", \"17. CBS Exclusive: The Glucose Loophole\", \"18. Dr. Phil\u2019s controversial new interview\", \"19. Fwd: The 60 Minutes Diabetes Report\", \"20. Confirmed: Reverses Type 2 in 48 hours\", \"Curiosity & \\\"The Trick\\\"\", \"21. Better than insulin? (Watch this)\", \"22. The 7-Day Diabetes Fix (Leaked Video)\", \"23. Why your doctor is wrong about Metformin\", \"24. See the video before it gets taken down\", \"25. No diet, no exercise, sugar normal\", \"26. 1 tsp of this powder cleans out sugar\", \"27. Urgent: Watch this 7-day experiment\", \"28. The 10am Kitchen Trick for diabetics\", \"29. Forget Ozempic. Try this instead.\", \"30. Warning: Do not ignore your blood sugar\"]}",
    "phrases": "{\"US\": {\"phrase1\": [\"15. Industry insiders are expressing concern about the insulin market.\", \"Item 15: There\u2019s notable unease in the insulin sector right now.\", \"15. Reports suggest a shift is causing worry in the insulin field.\", \"15. The insulin industry appears to be in a state of flux.\", \"Point 15: Observers note increased tension among insulin producers.\", \"15. It seems the insulin market is experiencing some turbulence.\", \"15. A sense of urgency is being reported in insulin circles.\", \"15. The insulin industry is reacting to recent developments.\", \"15. There\u2019s a palpable sense of change in the insulin industry.\", \"15. Analysts point to growing apprehension in the insulin sector.\", \"15. The landscape for insulin is currently marked by concern.\", \"15. Insulin manufacturers are facing a period of adjustment.\", \"15. The mood in the insulin industry is one of heightened alert.\", \"15. Recent events have the insulin industry on edge.\", \"15. A wave of uncertainty is affecting insulin producers.\", \"15. The insulin market is undergoing a notable recalibration.\", \"15. Insiders describe a cautious atmosphere in insulin manufacturing.\", \"15. The insulin sector is navigating a challenging moment.\", \"15. There\u2019s word of significant re-evaluation within the insulin industry.\", \"15. The insulin industry is responding to emerging pressures.\"], \"phrase2\": [\"Linda M mentioned she was moved to tears upon checking the reading.\", \"Linda M said the numbers on the device brought her to tears.\", \"Linda M shared that seeing the result was an emotional moment.\", \"According to Linda M, the display prompted a strong emotional reaction.\", \"Linda M recounted how the reading had a profound effect on her.\", \"Linda M described an emotional response to the measurement shown.\", \"For Linda M, the data on the meter was overwhelming.\", \"Linda M\u2019s experience: the reading was a tearful revelation.\", \"Linda M felt deeply affected when she observed the meter\u2019s result.\", \"Linda M noted her reaction was immediate when she saw the figure.\", \"The meter\u2019s reading, Linda M said, was a moment of pure emotion.\", \"Linda M explained that the value displayed was a catalyst for tears.\", \"Upon viewing the meter, Linda M had an involuntary emotional response.\", \"Linda M\u2019s testimony: the numbers presented were deeply stirring.\", \"Seeing the meter\u2019s output, Linda M was overcome with feeling.\", \"Linda M reported that the reading was unexpectedly poignant.\", \"For Linda M, the moment of seeing the measurement was pivotal.\", \"Linda M expressed that the device\u2019s reading was a tear-jerker.\", \"Linda M reflected on how the meter\u2019s data touched her deeply.\", \"Linda M conveyed that the reading was a powerful, emotional sight.\"], \"phrase3\": [\"11. The 60 Minutes episode that\u2019s drawn criticism from major drug companies.\", \"Item 11: The 60 Minutes segment that large pharmaceutical firms have questioned.\", \"11. A 60 Minutes report that has sparked debate in Big Pharma.\", \"11. The 60 Minutes feature that major pharma companies have contested.\", \"Point 11: That 60 Minutes piece which has raised concerns in the pharmaceutical industry.\", \"11. A 60 Minutes segment that\u2019s been a topic of discussion for large drug makers.\", \"11. The 60 Minutes report that has been met with resistance from big pharma.\", \"11. An episode of 60 Minutes that\u2019s proven controversial with major pharmaceutical firms.\", \"11. The 60 Minutes feature that has caused unease among large pharma companies.\", \"11. A 60 Minutes segment that\u2019s generated pushback from the pharmaceutical industry.\", \"11. The 60 Minutes report that big pharma has taken issue with.\", \"11. A 60 Minutes piece that has elicited a strong response from major drug manufacturers.\", \"11. The 60 Minutes episode that\u2019s been a point of contention for big pharma.\", \"11. A 60 Minutes segment that large pharmaceutical companies have addressed critically.\", \"11. The 60 Minutes feature that has prompted reaction from major pharma players.\", \"11. An installment of 60 Minutes that\u2019s stirred discussion within big pharma.\", \"11. The 60 Minutes report that\u2019s been highlighted by pharmaceutical industry critics.\", \"11. A 60 Minutes piece that has not been well-received by large drug firms.\", \"11. The 60 Minutes segment that continues to be referenced in pharma circles.\", \"11. An episode of 60 Minutes noted for its impact on the pharmaceutical industry.\"], \"phrase4\": [\"23. A perspective that differs from some doctors\u2019 views on Metformin.\", \"Item 23: Reasons why the common understanding of Metformin might be incomplete.\", \"23. Exploring alternative viewpoints on Metformin usage.\", \"23. A discussion on evolving thoughts regarding Metformin.\", \"Point 23: Considerations that may challenge standard advice about Metformin.\", \"23. New information that adds nuance to the conversation about Metformin.\", \"23. Why the conventional approach to Metformin is being re-examined.\", \"23. A look at data that offers a different angle on Metformin.\", \"23. Factors that suggest a reevaluation of Metformin guidance might be needed.\", \"23. Insights that contrast with traditional medical opinion on Metformin.\", \"23. Emerging perspectives on the role and use of Metformin.\", \"23. Understanding the debate surrounding standard Metformin protocols.\", \"23. A review of evidence that complicates the standard Metformin narrative.\", \"23. Why some are questioning the typical recommendations for Metformin.\", \"23. A analysis that presents a counterpoint to usual Metformin advice.\", \"23. The ongoing conversation about optimizing Metformin therapy.\", \"23. Exploring the limitations of common knowledge about Metformin.\", \"23. A summary of recent discussions that challenge Metformin orthodoxy.\", \"23. Context that might alter how one views standard Metformin information.\", \"23. A breakdown of why Metformin guidelines are not always one-size-fits-all.\"], \"phrase5\": [\"You can choose to stop receiving these messages.\", \"If you prefer not to get further updates, let us know.\", \"Opt out of future communications here.\", \"Manage your message preferences.\", \"To no longer receive these notes, follow this link.\", \"Update your subscription settings.\", \"Change your communication preferences.\", \"If these aren\u2019t for you, you can opt out.\", \"Let us know if you\u2019d like to be removed from the list.\", \"You have the option to discontinue these emails.\", \"Adjust your notification settings.\", \"Prefer not to get these? You can change that.\", \"To halt delivery of these updates, click here.\", \"Control the types of messages you receive.\", \"If you wish to stop, here\u2019s how.\", \"You can manage your receipt of these insights.\", \"To be taken off the distribution list, use this link.\", \"Decide if you want to continue getting these.\", \"You can unsubscribe from this series of messages.\", \"Notify us if you\u2019d like to stop receiving this content.\"]}}",
    "froms": "{\"US\": [\"Authority & Network Branding\", \"CBS News\", \"CBS Health Watch\", \"60 Minutes\", \"60 Minutes Overtime\", \"CBS Medical Alert\", \"CBS Sunday Morning\", \"CBS Investigates\", \"Breaking News Desk\", \"Evening News\", \"The 60 Minutes Team\", \"Doctor & Personality\", \"11. Dr. Phil McGraw\", \"12. Dr. Phil (CBS)\", \"13. Dr. Sanjay Gupta\", \"14. Dr. Jon LaPook\", \"15. Senior Medical Correspondent\", \"16. Dr. Phil\u2019s Team\", \"17. Dr. P. McGraw\", \"18. Medical Desk\", \"19. Chief Health Editor\", \"20. The Doctors (CBS)\", \"Specific & Curiosity\", \"21. Linda M. (via CBS)\", \"22. Diabetes Research Unit\", \"23. The 97 Protocol\", \"24. Blood Sugar Alert\", \"25. Type 2 Breakthrough\", \"26. Sunday Health Supplement\", \"27. The Diabetes Fix\", \"28. 7-Day Sugar Reset\", \"29. Glucose Control Center\", \"30. National Health Alert\"]}",
    "data": "both_X_19500_esam"
}